Aytu BioScience Return On Equity vs. Current Valuation
| AYTU Stock | USD 1.62 0.02 1.25% |
For Aytu BioScience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aytu BioScience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aytu BioScience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aytu BioScience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aytu BioScience over time as well as its relative position and ranking within its peers.
Aytu |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aytu BioScience. If investors know Aytu will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aytu BioScience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aytu BioScience is measured differently than its book value, which is the value of Aytu that is recorded on the company's balance sheet. Investors also form their own opinion of Aytu BioScience's value that differs from its market value or its book value, called intrinsic value, which is Aytu BioScience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aytu BioScience's market value can be influenced by many factors that don't directly affect Aytu BioScience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aytu BioScience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aytu BioScience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aytu BioScience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aytu BioScience Current Valuation vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aytu BioScience's current stock value. Our valuation model uses many indicators to compare Aytu BioScience value to that of its competitors to determine the firm's financial worth. Aytu BioScience is rated below average in return on equity category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Aytu BioScience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Aytu Current Valuation vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Aytu BioScience |
| = | -0.47 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Aytu BioScience |
| = | 6.29 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Aytu Current Valuation vs Competition
Aytu BioScience is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 15.49 Billion. Aytu BioScience adds roughly 6.29 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Aytu BioScience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aytu BioScience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aytu BioScience will eventually generate negative long term returns. The profitability progress is the general direction of Aytu BioScience's change in net profit over the period of time. It can combine multiple indicators of Aytu BioScience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado. Aytu Biopharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 164 people.
Aytu Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aytu BioScience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aytu BioScience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aytu BioScience's important profitability drivers and their relationship over time.
Use Aytu BioScience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aytu BioScience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will appreciate offsetting losses from the drop in the long position's value.Aytu BioScience Pair Trading
Aytu BioScience Pair Trading Analysis
The ability to find closely correlated positions to Aytu BioScience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aytu BioScience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aytu BioScience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aytu BioScience to buy it.
The correlation of Aytu BioScience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aytu BioScience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aytu BioScience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aytu BioScience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aytu BioScience position
In addition to having Aytu BioScience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Preferred Stock ETFs Thematic Idea Now
Preferred Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.